… -based phosphate binders and vitamin D therapy. In CKD … and phosphorus homeostasis that
may impact cardiovascular … -effectiveness of these treatments since even early stage CKD is …

… 2 but direct effects on the myocardium, such as cardiac … Patients receiving treatment with a
phosphate binder or vitamin … Our cohort of patients with early-stage CKD with a mean age of …

… phosphate binder used in advanced chronic kidney disease (… of sevelamer and their impact
on cardiovascular health, with … and diastolic function in patients with early-stage CKD. For …

… It is now appreciated that early stage chronic kidney disease (… , the effects of spironolactone
on arterial stiffness measured by … It follows that the use of phosphate binders in CKD has the …

… with CKD Stages 3 and 4 and involved varying phosphate binder treatment (… , “Effect of
spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: …

… that chronic kidney disease is an independent risk factor for … effects on arterial stiffness
through endothelial dysfunction.… the patients had been taking calcium-based phosphate binder, …

… impact of aortic stiffness on renal function has not been reported previously. A cohort of 133
patients with chronic kidney disease … , phosphate binders, or erythropoietin (data not shown). …

… are key contributors to chronic kidney disease (CKD)–… indication for treatment to control
phosphorus in early stage CKD… phosphate binder therapy in those with some kidney function, …

… hallmark of progression in chronic kidney disease (CKD) and … the treatment protocol, an
approach which could impact the … to assess the effects of a phosphate binder treatment against …

… interest in the effects of chronic kidney disease (CKD)-… in CKD patients and occurs even in
the early stage of the disease. … and the calcium-based phosphate binders (CBPBs) CaCO 3 …